Epigenome Reprogramming Through H3K27 and H3K4 Trimethylation as a Resistance Mechanism to DNA Methylation Inhibition in BRAFV600E-Mutated Colorectal Cancer
Key Discovery Milestones With active concentrations in the nanomolar range (10 M) and a safety margin 300-fold above therapeutic doses, GHK-Cu combines potent biological activity with an excellent safety profile established through decades of clinical use and research studies published in peer-reviewed journals like PubMed
Vitamin B2 (Riboflavin) It is a powerful antioxidant and plays a vital role in maintaining healthy blood cells and boosts metabolism
Fukui, S., Schwarcz, R., Rapoport, S
In der Forschung wird GHK-Cu seit vielen Jahren im Zusammenhang mit Gewebereparatur und regenerativen Prozessen untersucht
In theory, GCs help treat SAH through their anti-inflammatory properties